The following table lists the largest mergers and acquisitions in the pharmaceutical and biotechnology industry (those over $10 billion). Transactions are recorded by the highest transaction dollar value (rather than using the inflation adjusted values).
Largest mergers and acquisitions
This list is incomplete, you can help by expanding it
Failed mergers and acquisitions
See also
References
- FirstWord Lists The 20 largest pharma M&A deals^
- Pfizer, W-L strike deal CNN, 7 February 2000, retrieved 6 January 2019^
- Bristol-Myers set $2.2 billion termination fee for their mega deal^
- Allergan Accelerates Transformation to Branded Growth Pharma Leader by Divesting Global Generics Business to Teva for $40.5 Billion Allergan, 27 July 2015, retrieved 27 November 2015^
- Cynthia Koons. Teva CEO: $40.5 Billion Allergan Deal is Just the Beginning Bloomberg, 27 July 2015, retrieved 27 November 2015^
- Chitra Somayaji. Teva Snaps Up Allergan's Generics Arm, Dumping Mylan Bloomberg, 27 July 2015, retrieved 27 November 2015^
- Antoine Gara. Pfizer And Allergan Merger Ranks As Biggest-Ever Pharmaceutical Deal Forbes^
- Japan's Takeda clinches £45.3 billion Shire deal as pharma M&A rolls on May 9, 2018^
- FirstWord Lists – The 20 largest pharma M&Adeals^
- Daniel Gilbert. Novo Nordisk buys manufacturing power as it seeks to ramp up Wegovy The Washington Post, 2024-02-05^
- Annika Kim Constantino. Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply CNBC, 2024-02-05^
- Pfizer Ends $160B Acquisition of Allergan after U.S. Crackdown on Inversions GEN, 6 April 2016^
- Pfizer, Allergan Agree to End $160 Billion Deal Bloomberg.com, 6 April 2016^
- M&A Boom Implodes, US Deal Failures in 2016 Worst Ever 7 April 2016^
- Sean Farrell, Rowena Mason. AstraZeneca rejects Pfizer's final £69bn takeover bid The Guardian, 19 May 2014^
- Pfizer chases AstraZeneca for potential $100 billion deal 28 April 2017^
- Warner-Lambert rejects Pfizer's bid - Nov. 4, 1999^
- Pfizer Makes Bid for Warner-Lambert (washingtonpost.com) The Washington Post^
- WARNER-LAMBERT GETS PFIZER OFFER FOR $82.4 BILLION The New York Times, 5 November 1999^
- Warner Lambert. - Pfizer: One of the world's premier biopharmaceutical companies^
- Robert Langreth, Steven Lipin. American Home Products Discusses A Merger With Warner-Lambert Wall Street Journal, 3 November 1999^
- Bayer sweetens Monsanto bid as talks enter final stretch September 6, 2016^
- Bayer confirms $66bn Monsanto takeover BBC News, September 14, 2016^
- Statement re Proposal from Takeda Pharmaceutical Company Limited www.shire.com^
- Allergan agrees to $66 billion Actavis offer; Valeant walks 17 November 2016^
- Valeant Raises Takeover Offer for Allergan a Second Time Bloomberg, 31 May 2014^
- Valeant Raises Takeover Offer for Allergan With More Cash Bloomberg, 28 May 2014^
- Antoine Gara. Monsanto Drops $46.5B Bid For Syngenta, Paving Way For Stock Buyback Amid Market Rout Forbes^
- Yoel Minkoff. Syngenta rejects Monsanto's takeover approach Seeking Alpha, May 8, 2015^
- Carl Surran. Reuters: Monsanto, Syngenta hire U.S. banks to advise on possible takeover Seeking Alpha, May 7, 2015^
- Valeant, Bill Ackman bid $45B for Botox-maker Allergan^
- Monsanto Said to Have Weighed $40 Billion Syngenta Deal www.bloomberg.com, 24 June 2014, retrieved 6 January 2019^
- Teva Offers to Buy Mylan for $40B Genetic Engineering & Biotechnology News, April 21, 2015, retrieved April 21, 2015^
- Mylan Offers $28.9B for Perrigo Genetic Engineering & Biotechnology News, April 8, 2015, retrieved April 21, 2015^
- Teva Offers to Buy Mylan in $40.1B Cash-And-Stock Deal Pharmaceutical Processing, April 21, 2015, retrieved April 21, 2015^
- Mylan's Hostile Bid for Perrigo Fails^
- Endo Ends Effort to Wrest Merger-Bound Salix from Valeant - GEN Genetic Engineering & Biotechnology News - Biotech from Bench to Business - GEN 16 March 2015^